Archie is where Cochrane Groups manage people, reviews and other documents. Access to Archie is reserved for Cochrane editorial teams, authors of Cochrane reviews, and staff of Cochrane groups with relevant roles. Getting started. To use Archie, you must have a personal Cochrane Account, and a role within Cochrane that allows you to access Archie.
Zefram Cochrane | |
---|---|
Star Trek character | |
Zefram Cochrane as portrayed by James Cromwell in Star Trek: First Contact | |
First appearance | 'Metamorphosis' (Star Trek: The Original Series) |
Portrayed by | Glenn Corbett(1967) James Cromwell(1996–2001) |
Information | |
Species | Human |
Affiliation | Earth |
Zefram Cochrane is a fictional character in the Star Trekuniverse. Created by writer Gene L. Coon, the character first appeared in the 1967 Star Trek episode 'Metamorphosis', in which he was played by Glenn Corbett. James Cromwell later played Cochrane in the 1996 feature film Star Trek: First Contact and the 2001 Star Trek: Enterprise pilot, 'Broken Bow'. Footage of Cromwell from Star Trek: First Contact was used in the Enterprise episode 'In a Mirror, Darkly (Part I)', along with new footage of an identically-dressed actor whose face is not shown.
As first mentioned in Star Trek: The Original Series, and further established by the events of Star Trek: First Contact, Cochrane is the first human to create a warp drive system, and in 2063, his successful warp speed flight draws the attention of the Vulcans, leading to humanity's first official contact with an alien race.
- 1Fictional character biography
Fictional character biography[edit]
Cochrane was born in 2030, according to Star Trek: First Contact (though the novelization of that film gives his year of birth as 2013). He constructed humanity's first warp-capable vessel, the Phoenix, in Bozeman, Montana, out of an old Titan IInuclearmissile.[1][2] He started the project for financial gain, and found the accounts of his future accolades as told by the crew of the Enterprise-E from the future deeply disturbing.[1][3]
On April 5, 2063, Cochrane made Earth's first warp flight, playing Steppenwolf's 'Magic Carpet Ride' during blast-off. The Phoenix's warp flight was detected by a Vulcan survey ship, the T'Plana Hath, which then makes peaceful first contact with humans, including Cochrane, at the Phoenix's launch site.[1]
The aphorism 'Don't try to be a great man, just be a man. And let history make its own judgments.' is attributed to Cochrane, who is said to have uttered it in 2073.[4] In 2119, Cochrane was present at the dedication of Earth's first Warp 5 Complex, as seen in a video viewed by the characters in the 2001 pilot episode of Star Trek: Enterprise. On that occasion, Cochrane stated, 'This engine will let us go boldly where no man has gone before', making him the earliest known person in the fictional timeline of Trek to say that phrase.[5]
The Phoenix's launch facility became a historical monument. A 20-meter marble statue was erected there, depicting Cochrane heroically reaching toward the future. Cochrane's name became revered among humans, with entire universities, cities and planets named after him.[6]Enterprise-D and Enterprise-EChief EngineerGeordi La Forge, for example, attended Zefram Cochrane High School.[7]
According to the original Star Trek episode 'Metamorphosis', Cochrane was presumed dead after disappearing from Alpha Centauri in 2117 (though the Star Trek: Enterprise episode 'Broken Bow' later retcons the year of Cochrane's disappearance to be 2119 or later). James T. Kirk, Spock and Leonard McCoy find Cochrane living on an asteroid with a being he calls the Companion, an ethereal presence of pure energy who rejuvenated the aged, dying Cochrane 150 years earlier, and has held him captive—and in a state of youth and vigor—ever since. Nancy Hedford, who was traveling with the three Starfleet officers, is an ill Federation commissioner. The Companion, who loves Cochrane, merges with the commissioner, ridding her of her illness and providing the Companion with a corporeal (but now mortal) form. The combined entity no longer has power to force Cochrane to stay with her, but Cochrane chooses to stay out of love and gratitude. Before departing, Kirk, Spock and McCoy promise not to reveal Cochrane's existence.[1]
Mirror Universe[edit]
In the Mirror Universe, rather than reciprocating the Vulcans' peaceful greeting, Cochrane and the other humans kill the Vulcans and loot their ship.[8] Humans conquer other worlds as part of the brutal Terran Empire.[9]
Appearance[edit]
Glenn Corbett as Cochrane with Elinor Donahue as Nancy Hedford in the 1967 Star Trek episode 'Metamorphosis'.
In 'Metamorphosis', Cochrane was played by Glenn Corbett, who was 34 at the time of that episode's airing. In Star Trek: First Contact, Cochrane was played by the 56-year-old James Cromwell, at a point when the character, in 2063, would have been approximately 33 years old.[10]The Star Trek Encyclopedia explains this discrepancy by theorizing that Cochrane's aged appearance in 2063 was the result of radiation poisoning, and that when he encountered the Companion, the Companion reversed these effects, and restored his youthful appearance.[1]
Non-canonical treatment[edit]
In the 1994 novel Federation by Judith and Garfield Reeves-Stevens, whose publication predated the release of Star Trek: First Contact by two years, Cochrane had been portrayed as a human of Earth origin. The novel suggested he retired to Alpha Centauri at some point between his first warp flight and his disappearance.[11] This follows a suggestion made in the Star Trek Chronology, on the assumption humans could not have settled the Alpha Centauri system prior to the warp drive's invention.[12]
In the novel, Cochrane's warp experiments are the result of a mysterious billionaire's financial and idealistic support in the period between the Eugenics Wars and World War III. His self-identification with Alpha Centauri results from it being the destination of his first warp voyage and his subsequent founding role in the first colony in the system. His life's story beyond his encounter with Kirk at Gamma Canaris in 'Metamorphosis' is depicted up to his death during the events of the third season of Star Trek: The Next Generation.[11]
In the 1989 reference book Worlds of the Federation, author Shane Johnson writes of Zefram Cochrane being a native to the Alpha Centauri system (which is populated by humans transplanted from Earth in antiquity) who is contacted by the United Nations spaceship Icarus, a sublight vessel which is the first human ship to travel to another solar system.
Lacking a common language and before the invention of the universal translator, he used mathematics alone to communicate his ideas for a faster-than-light drive system and its prototype, the WD-1.[13]
Cochrane also appeared in issue #49 of Gold Key Comics's Star Trek series, along with Nancy Hedford and the Companion.[14]
References[edit]
- ^ abcdeOkuda, Mike and Denise, with Debbie Mirek (1999). The Star Trek Encyclopedia. Pocket Books. ISBN0-671-53609-5.CS1 maint: Multiple names: authors list (link)
- ^Star Trek: First Contact only referenced 'central Montana' as the location, with Bozeman only later identified as the specific city by Hoshi Sato in the 2002 Star Trek: Enterprise episode 'Desert Crossing'.
- ^Cochrane's statements in Star Trek: First Contact (1996); Paramount Pictures
- ^Riker mentions this to Cochrane as they prepare for the Phoenix's launch in Star Trek: First Contact.
- ^Berman, Rick; Braga, Brannon. 'Broken Bow'; Star Trek: Enterprise (UPN). September 26, 2001.
- ^Gene L. Coon. 'Metamorphosis'; Star Trek: The Original Series; November 10, 1967
- ^Geordi LaForge mentions this to Cochrane during the Earthbound scenes of Star Trek: First Contact.
- ^Mike Sussman, James L. Conway (April 22, 2005). 'In a Mirror, Darkly, part I'. Star Trek: Enterprise. UPN.
- ^Marc Daniels, Jerome Bixby (October 6, 1967). 'Mirror, Mirror'. Star Trek. NBC.
- ^The character was stated in 'Metamorphosis' to have been 87 years old in 2117, and was therefore born in 2030, as pointed out by The Star Trek Encyclopedia. Page 26 of The Star Trek Chronology (second edition) also gives 2030 as his year of birth.
- ^ abReeves-Stevens, Judith and Garfield (1994-11-01). Federation. Star Trek. Pocket Books. ISBN0-671-89422-6.
- ^Okuda, Mike and Denise (1993). Star Trek Chronology. Pocket Books. ISBN0-671-79611-9.
- ^Johnson, Steve (1989-11-01). Worlds of the Federation. Star Trek. Pocket Books. ISBN0-671-70813-9.
- ^Kashdan, George (1977). Star Trek #49 ('A Warp in Space'). Gold Key Comics.
External links[edit]
- Zefram Cochrane at Memory Alpha (a Star Trekwiki)
- Article about Federation (novel) at Memory Alpha
Retrieved from 'https://en.wikipedia.org/w/index.php?title=Zefram_Cochrane&oldid=902295836'
Pronunciation | |
---|---|
Motto | Trusted evidence. Informed decisions. Better health. |
Formation | 1993; 26 years ago (as Cochrane Collaboration) |
Type | Charity in UK |
Purpose | Independent research into data about health care |
Headquarters | London, England[1] |
Region served | Worldwide |
English | |
Leader | Martin Burton and Margerite Koster[2] |
Volunteers | Over 37,000 (2015) [3] |
Website | www.cochrane.org |
Cochrane Collaboration |
Cochrane is a British charity[4] formed to organise medical research findings so as to facilitate evidence-based choices about health interventions faced by health professionals, patients, and policy makers.[5][6] Cochrane includes 53 review groups that are based at research institutions worldwide. Cochrane has approximately 30,000 volunteer experts from around the world.[7]
The group conducts systematic reviews of health-care interventions and diagnostic tests and publishes them in the Cochrane Library.[8][5] According to the Library articles are available via one-click access but some require paid subscription or registration before reading.[9][10] A few reviews, in occupational health for example, incorporate results from non-randomised observational studies,[8] as well as controlled before–after (CBA) studies and interrupted time-series studies.[11]
- 4Partnerships
History[edit]
Cochrane, previously known as the Cochrane Collaboration, was founded in 1993 under the leadership of Iain Chalmers.[12] It was developed in response to Archie Cochrane's call for up-to-date, systematic reviews of all relevant randomised controlled trials in the field of healthcare.[13][14][15]
In 1998, the Cochrane Economics Methods Group (CEMG) was established to facilitate the basing of decisions on health economics, evidence-based medicine and systematic reviews.[16]
Cochrane's suggestion that methods used to prepare and maintain reviews of controlled trials in pregnancy and childbirth be applied more widely was taken up by the Research and Development Programme, initiated to support the National Health Service. Through the NHS research and development programme, led by Michael Peckham,[17][when?] funds were provided to establish a 'Cochrane Centre', to collaborate with others, in the UK and elsewhere, to facilitate systematic reviews of randomised controlled trials across all areas of healthcare.[18][when?]
In 2004, the Campbell Collaboration joined with the CEMG to form the Campbell & Cochrane Economics Methods Group (CCEMG).[19][20]
In 2013 the organization published an editorial describing its efforts to train people in developing nations to perform Cochrane reviews.[21] A 2017 editorial briefly discussed the history of Cochrane methodological approaches, such as including studies that use methodologies in lieu of randomised control trials and the challenge of having evidence adopted in practice.[11]
During its 2018 annual meeting, the Cochrane board expelled Peter Gøtzsche, board member and director of Cochrane's Nordic center, from the organization, telling Nature that it had received 'numerous complaints' about Gøtzsche after he co-authored an article in BMJ Evidence-Based Medicine alleging bias in Cochrane's May 2018[22] review of HPV vaccines. Gøtzsche's expulsion led four elected board members to resign in protest, which in turn led the board to cut two appointed members in order to comply with the ratio of elected to appointed members required by the organization's charter.[23] Gøtzsche announced that this had happened via an open letter, in which he said there is a 'growing top-down authoritarian culture and an increasingly commercial business model' taking root at Cochrane that 'threaten the scientific, moral and social objectives of the organization'. Gøtzsche remains an outspoken critic of Cochrane's relationship with the pharmaceutical industry. The Cochrane board stated that Gøtzsche was expelled for his behavior, which had been reviewed by an independent counsel hired by Cochrane.[23]
Logo[edit]
A blobbogram of seven studies of giving corticosteroids to women about to give birth too early; a similar blobbogram of the same data is shown, stylised, in part of the Cochrane logo.
The Cochrane logo represents a meta-analysis of data from seven randomised controlled trials (RCTs), comparing one health care treatment with a placebo in a blobbogram or forest plot. The diagram shows the results of a systematic review and meta-analysis on inexpensive course of corticosteroid given to women about to give birth too early – the evidence on effectiveness that would have been revealed had the available RCTs been reviewed systematically around 1982. This treatment reduces the odds of the babies of such women dying from the complications of immaturity by 30–50%. Because no systematic review of these trials was published until 1990,[24][25] most obstetricians had not realised that the treatment was so effective and therefore many premature babies probably suffered or died unnecessarily.[25]
Reception[edit]
A 2004 editorial in the Canadian Medical Association Journal noted that Cochrane reviews appear to be more up to date and of better quality than other reviews, describing them as 'the best single resource for methodologic research and for developing the science of meta-epidemiology' and crediting them with leading to methodological improvements in the medical literature.[26]
Studies comparing the quality of Cochrane meta-analyses in the fields of infertility,[27]physiotherapy,[27][28] and orthodontics[29] to those published by other sources have concluded that Cochrane reviews incorporate superior methodological rigor. A broader analysis across multiple therapeutic areas reached similar conclusions but was performed by Cochrane authors.[30]Compared to non-Cochrane reviews, those from Cochrane are less likely to reach a positive conclusion about the utility of medical interventions.[31] Key criticisms that have been directed at Cochrane's studies include a failure to include a sufficiently large number of unpublished studies, failure to pre-specify or failure to abide by pre-specified rules for endpoint[32] or trial[33] inclusion, insufficiently frequent updating of reviews, an excessively high percentage of inconclusive reviews,[34] and a high incidence of ghostwriting and honorary authorship.[35][36] In some cases Cochrane's internal structure may make it difficult to publish studies that run against the preconceived opinions of internal subject matter experts.[37]
Partnerships[edit]
World Health Organization[edit]
Cochrane maintains an official relationship with the World Health Organization[38] that affords Cochrane the right to appoint nonvoting representatives to WHO meetings, including sessions of the World Health Assembly, and make statements on WHO resolutions.[39]
Wikipedia[edit]
Wikipedia and Cochrane collaborate to increase the incorporation of Cochrane research into Wikipedia articles and provide Wikipedia editors with resources for interpreting medical data.[40] Cochrane and John Wiley and Sons, publisher of Cochrane reviews, make one hundred free Cochrane accounts available to Wikipedia medical editors—the financial value of which has been estimated by Cochrane at between thirty thousand and eighty thousand dollars per annum—and pay a nominal stipend and travel expenses to support a Wikipedian in Residence at Cochrane.[41]
In 2014 the Cochrane blog hosted a rebuttal, written by four Wikipedia medical editors, of an article published in the Journal of the American Osteopathic Association that was critical of the accuracy of Wikipedia medical content.[42][43]
See also[edit]
Public involvement[edit]
Cochrane has a number of tasks that the public can do, associated with producing systematic reviews and other outputs. Tasks can be organised as 'entry level' or higher. Tasks includes:
- Joining a collaborative volunteer effort to help categorise and summarise healthcare evidence[44]
- Data extraction and risk of bias assessment
- translation of reviews into other languages
A recent systematic review of how people were involved in systematic reviews aimed to document the evidence-base relating to stakeholder involvement in systematic reviews and to use this evidence to describe how stakeholders have been involved in systematic reviews.[45] Thirty percent involved patients and/or carers.
While there has been some criticism of how Cochrane prioritises systematic reviews,[46] a recent project involved people in helping identify research priorities to inform future Cochrane Reviews.[47]
In 2014, the Cochrane-Wikipedia partnership was formalised. This supports the inclusion of relevant evidence within all Wikipedia medical articles, as well as processes to help ensure that medical information included in Wikipedia is of the highest quality and accuracy.[48]
References[edit]
- ^'The Cochrane Collaboration'. Charity Commission. Retrieved 9 December 2017.
- ^'Team'. Cochrane. Retrieved 9 December 2017.
- ^'About us | Cochrane'. www.cochrane.org. Retrieved 14 September 2015.
- ^'Articles of Association'(PDF).
- ^ ab'Public Health Guidelines'. NIH Library. Retrieved 20 November 2017.
- ^Hill GB (December 2000). 'Archie Cochrane and his legacy. An internal challenge to physicians' autonomy?'. J Clin Epidemiol. 53 (12): 1189–92. doi:10.1016/S0895-4356(00)00253-5. PMID11146263.
- ^Sepkowitz, Kent A. (14 May 2014). 'Looking for the Final Word on Treatment'. The New York Times.
- ^ abKongsted, Hans; Konnerup, Merete (2012). 'Are more observational studies being included in Cochrane reviews?'. BMC Research Notes. 5 (1): 570. doi:10.1186/1756-0500-5-570. PMC3503546. PMID23069208.
- ^'Access Options for Cochrane Library'. www.cochranelibrary.com. Retrieved 5 July 2018.
- ^'How to order the Cochrane Library'. www.cochranelibrary.com. Retrieved 5 July 2018.
- ^ abRuotsalainen, Jani; Sauni, Riitta; Verbeek, Jos (2017). 'Cochrane Work—championing facts since 2003'. Occupational Medicine. 67 (7): 504–506. doi:10.1093/occmed/kqx073. PMID29048596.
- ^Ault, Alicia (27 June 2003). 'Clinical research. Climbing a medical Everest'. Science. 300 (5628): 2024–2025. doi:10.1126/science.300.5628.2024. PMID12829761.
- ^Thomas, Katie (29 June 2013). 'The Cochrane Collaboration'. The New York Times.
- ^Chalmers, I; Dickersin, K; Chalmers, TC (1992). 'Getting to grips with Archie Cochrane's agenda'. BMJ. 305 (6857): 786–788. doi:10.1136/bmj.305.6857.786. PMC1883470. PMID1422354.
- ^Winkelstein Jr., W (September 2009). 'The Remarkable Archie: Origins of the Cochrane Collaboration'. Epidemiology. 20 (5): 779. doi:10.1097/EDE.0b013e3181aff391. PMID19680039.
- ^http://file.zums.ac.ir/ebook/085-Evidence-Based%20Health%20Economics%20(Evidence-Based%20Medicine)-Miranda%20Mugford%20Luke%20Vale%20Cam%20Donal.pdf
- ^Peckham M (August 1991). 'Research and development for the National Health Service'. Lancet. 338 (8763): 367–71. doi:10.1016/0140-6736(91)90494-A. PMID1677710.
- ^Dickersin K, Manheimer E (1998). 'The Cochrane Collaboration: evaluation of health care and services using systematic reviews of the results of randomized controlled trials'. Clinical Obstetrics & Gynecology. 41 (2): 315–331. doi:10.1097/00003081-199806000-00012. PMID9646964.
- ^Shemilt, I; Mugford, M; Drummond, M; Eisenstein, E; Mallender, J; McDaid, D; Vale, L; Walker, D; The Campbell & Cochrane Economics Methods Group (CCEMG) (2006). 'Economics methods in Cochrane systematic reviews of health promotion and public health related interventions'. BMC Medical Research Methodology. 6: 55. doi:10.1186/1471-2288-6-55. PMC1660547. PMID17107612.
- ^'Welcome'.
- ^Young T, Garner P, Kredo T, Mbuagbaw L, Tharyan P, Volmink J (2013). 'Cochrane and capacity building in low- and middle-income countries: where are we at? [editorial]'. Cochrane Database of Systematic Reviews. 11 (11): ED000072. doi:10.1002/14651858.ED000072. PMID24524153.
- ^Jørgensen, Lars; Gøtzsche, Peter C.; Jefferson, Tom (2018). 'The Cochrane HPV vaccine review was incomplete and ignored important evidence of bias'. BMJ Evidence-Based Medicine. 23 (5): 165–168. doi:10.1136/bmjebm-2018-111012. PMID30054374.
- ^ abVesper, Inga (17 September 2018). 'Mass resignation guts board of prestigious Cochrane Collaboration'. Nature. doi:10.1038/d41586-018-06727-0.
- ^Crowley, P; Chalmers, I; Keirse, MJ (January 1990). 'The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials'. British Journal of Obstetrics and Gynaecology. 97 (1): 11–25. doi:10.1111/j.1471-0528.1990.tb01711.x. PMID2137711.
- ^ ab'Our logo | Cochrane'. www.cochrane.org. Retrieved 25 September 2016.
- ^Grimshaw, J. (2004). 'So what has the Cochrane Collaboration ever done for us? A report card on the first 10 years'. Canadian Medical Association Journal. 171 (7): 747–749. doi:10.1503/cmaj.1041255. PMC517860. PMID15451837.
- ^ abWindsor B, Popovich I, Jordan V, Showell M, Shea B, Farquhar C (December 2012). 'Methodological quality of systematic reviews in subfertility: a comparison of Cochrane and non-Cochrane systematic reviews in assisted reproductive technologies'. Hum. Reprod. 27 (12): 3460–6. doi:10.1093/humrep/des342. PMID23034152.
- ^Moseley, Anne M.; Elkins, Mark R.; Herbert, Robert D.; Maher, Christopher G.; Sherrington, Catherine (October 2009). 'Cochrane reviews used more rigorous methods than non-Cochrane reviews: survey of systematic reviews in physiotherapy'. Journal of Clinical Epidemiology. 62 (10): 1021–1030. doi:10.1016/j.jclinepi.2008.09.018. PMID19282144.
- ^Fleming PS, Seehra J, Polychronopoulou A, Fedorowicz Z, Pandis N (April 2013). 'Cochrane and non-Cochrane systematic reviews in leading orthodontic journals: a quality paradigm?'. Eur J Orthod. 35 (2): 244–8. doi:10.1093/ejo/cjs016. PMID22510325.
- ^Olsen O, Middleton P, Ezzo J, et al. (October 2001). 'Quality of Cochrane reviews: assessment of sample from 1998'. BMJ. 323 (7317): 829–32. doi:10.1136/bmj.323.7317.829. PMC57800. PMID11597965.
- ^Tricco AC, Tetzlaff J, Pham B, Brehaut J, Moher D (April 2009). 'Non-Cochrane vs. Cochrane reviews were twice as likely to have positive conclusion statements: cross-sectional study'. J Clin Epidemiol. 62 (4): 380–386.e1. doi:10.1016/j.jclinepi.2008.08.008. PMID19128940.
- ^Tendal B, Nüesch E, Higgins JP, Jüni P, Gøtzsche PC (2011). 'Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study'. BMJ. 343: d4829. doi:10.1136/bmj.d4829. PMC3171064. PMID21878462.
- ^Hutton P, Morrison AP, Yung AR, Taylor PJ, French P, Dunn G (July 2012). 'Effects of drop-out on efficacy estimates in five Cochrane reviews of popular antipsychotics for schizophrenia'(PDF). Acta Psychiatr Scand. 126 (1): 1–11. doi:10.1111/j.1600-0447.2012.01858.x. PMID22486554.
- ^Green-Hennessy S (January 2013). 'Cochrane systematic reviews for the mental health field: is the gold standard tarnished?'. Psychiatr Serv. 64 (1): 65–70. doi:10.1176/appi.ps.001682012. PMID23117176.
- ^Mowatt, G; Shirran, L; Grimshaw, JM; Rennie, D; Flanagin, A; Yank, V; MacLennan, G; Gøtzsche, PC; Bero, LA (5 June 2002). 'Prevalence of honorary and ghost authorship in Cochrane reviews'. JAMA. 287 (21): 2769–71. doi:10.1001/jama.287.21.2769. PMID12038907.
- ^Tisdale JE (November 2009). 'Integrity in authorship and publication'. Can J Hosp Pharm. 62 (6): 441–7. doi:10.4212/cjhp.v62i6.840. PMC2827013. PMID22478931.
- ^'www.radcliffehealth.com'(PDF). Archived from the original(PDF) on 5 September 2014.
- ^'Non-State actors in official relations with WHO'. World Health Organization. Retrieved 26 July 2017.
- ^'World Health Organization | Cochrane'. www.cochrane.org. Retrieved 17 October 2015.
- ^Mathew, Manu; Joseph, Anna; Heilman, James; Tharyan, Prathap (2013). 'Cochrane and Wikipedia: the collaborative potential for a quantum leap in the dissemination and uptake of trusted evidence[editorial]'. Cochrane Database of Systematic Reviews. 10 (10): ED000069. doi:10.1002/14651858.ED000069. PMID24475488.
- ^Orlowitz, Jake (5 May 2014). 'Cochrane Collaboration Recruits Talented Wikipedian In Residence'. Wikimedia Foundation Global Blog. Wikimedia Foundation. Retrieved 15 September 2015. Cross-posted on Cochrane Official Blog, 13 May 2014.
- ^Chatterjee, Anwesh; Cooke, Robin M.T.; Furst, Ian; Heilman, James (23 June 2014). 'Is Wikipedia's medical content really 90% wrong?'. Cochrane Community. www.cochrane.org. Archived from the original on 5 October 2015. Retrieved 15 September 2015.
- ^Hasty RT, Garbalosa RC, Barbato VA, et al. (May 2014). 'Wikipedia vs peer-reviewed medical literature for information about the 10 most costly medical conditions'. J Am Osteopath Assoc. 114 (5): 368–73. doi:10.7556/jaoa.2014.035. PMID24778001.
- ^'Cochrane crowd'. crowd.cochrane.org. Retrieved 14 February 2019.
- ^Pollock A, Campbell P, Struthers C, Synnot A, Nunn J, Hill S, Goodare H, Morris J, Watts C, Morley R (November 2018). 'Stakeholder involvement in systematic reviews: a scoping review'. Systematic Reviews. 7 (1): 208. doi:10.1186/s13643-018-0852-0. PMC6260873. PMID30474560.
- ^Newman M (January 2019). 'Has Cochrane lost its way?'. BMJ. 364: k5302. doi:10.1136/bmj.k5302. PMID30606713.
- ^Synnot A, Bragge P, Lowe D, Nunn JS, O'Sullivan M, Horvat L, Tong A, Kay D, Ghersi D, McDonald S, Poole N, Bourke N, Lannin N, Vadasz D, Oliver S, Carey K, Hill SJ (May 2018). 'Research priorities in health communication and participation: international survey of consumers and other stakeholders'. BMJ Open. 8 (5): e019481. doi:10.1136/bmjopen-2017-019481. PMC5942413. PMID29739780.
- ^'The Cochrane-Wikipedia partnership in 2016'. Cochrane. Retrieved 24 February 2019.
External links[edit]
- Official website
Retrieved from 'https://en.wikipedia.org/w/index.php?title=Cochrane_(organisation)&oldid=899892937'